MEDS

DataMEDS AI, Inc.

$0.90

-8.96%
SectorHealthcareIndustryMedical DistributionCountryUnited States

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services. DataMEDS AI, Inc., through its subsidiary develops and delivers a portfolio of products to guide physicians and patients with difficult clinical decisions throughout the cancer care continuum. In addition, the company develops and provides functional precision medicine oncology platform. The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Source: Yahoo Finance
Q-Score21/ 100
Market Cap$4.6M
P/E—
Dividend Yield0.00%
52-Week Range—
Next Earnings—
Analysts—
Beta0.95
AI summary

Price & performance

1M+75.9%
3M+0.3%
YTD-86.9%
1Y-90.2%
52-week range—
Beta0.95
Full chart and returns against a benchmark

Q-Score

21/ 100

Quality against peers; 50 is the peer median.

Growth28
Risk18
Performance46
Valuation39
Profitability5
Leverage22
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$23.3M+28.7%
Net income-$101.3M
Net margin-433.9%-396.1 pts
Historical fundamentals

Red flags in filings

5active red flags
Going-concern doubtMar 20, 2026
Material weakness in controlsMar 20, 2026
Late filing noticeAug 14, 2026
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Largest customer13%
Regions, segments, customers and suppliers

Valuation

MEDSIndustryP/E—28.60P/S0.580.25EV/EBITDA—17.46P/B——PEG—0.72
Dividend yield0.00%
Every valuation metric